Julia C Chisholm

Summary

Affiliation: Great Ormond Street
Country: UK

Publications

  1. ncbi request reprint Pharmacokinetics of dactinomycin in a pediatric patient population: a United Kingdom Children's Cancer Study Group Study
    Gareth J Veal
    Northern Institute for Cancer Research, University of Newcastle upon Tyne, UK
    Clin Cancer Res 11:5893-9. 2005
  2. ncbi request reprint The evolution towards ambulatory and day-case management of febrile neutropenia
    Julia C Chisholm
    Department of Haematology and Oncology, Great Ormond Street Hospital, London, UK
    Br J Haematol 135:3-16. 2006
  3. ncbi request reprint Influenza immunisation in children with solid tumours
    J Chisholm
    Department of Paediatric Oncology, Great Ormond Street Hospital, Great Ormond Street, London WC1N 3JH, UK
    Eur J Cancer 41:2280-7. 2005
  4. ncbi request reprint Efficacy of carboplatin given in a phase II window study to children and adolescents with newly diagnosed metastatic soft tissue sarcoma
    J C Chisholm
    Department of Haematology and Oncology, Great Ormond Street Hospital, Great Ormond Street, London WC1N 3JH, UK
    Eur J Cancer 43:2537-44. 2007
  5. ncbi request reprint Toxicity and outcome of children and adolescents participating in phase I/II trials of novel anticancer drugs: the Royal Marsden experience
    Daniel A Morgenstern
    Pediatric Drug Development Unit, Children and Young People s Unit, The Royal Marsden NHS Foundation Trust Pediatric Drug Development Team, Divisions of Cancer Therapeutics and Clinical Studies, The Institute of Cancer Research, Sutton Pediatric Oncology Department, Great Ormond Street Hospital Institute of Child Health, University College London, London, UK
    J Pediatr Hematol Oncol 36:218-23. 2014
  6. pmc Variation in policies for the management of febrile neutropenia in United Kingdom Children's Cancer Study Group centres
    Bob Phillips
    Paediatric Oncology Day Hospital, St James s Hospital, Leeds, UK
    Arch Dis Child 92:495-8. 2007
  7. doi request reprint Vaccinations in children treated with standard-dose cancer therapy or hematopoietic stem cell transplantation
    Soonie R Patel
    Paediatric Department, Mayday University Hospital, Croydon, UK
    Pediatr Clin North Am 55:169-86, xi. 2008

Detail Information

Publications7

  1. ncbi request reprint Pharmacokinetics of dactinomycin in a pediatric patient population: a United Kingdom Children's Cancer Study Group Study
    Gareth J Veal
    Northern Institute for Cancer Research, University of Newcastle upon Tyne, UK
    Clin Cancer Res 11:5893-9. 2005
    ..Despite concerns over the incidence of toxicity, little is known about the pharmacology of dactinomycin. A study was done to investigate dactinomycin pharmacokinetics in children...
  2. ncbi request reprint The evolution towards ambulatory and day-case management of febrile neutropenia
    Julia C Chisholm
    Department of Haematology and Oncology, Great Ormond Street Hospital, London, UK
    Br J Haematol 135:3-16. 2006
    ....
  3. ncbi request reprint Influenza immunisation in children with solid tumours
    J Chisholm
    Department of Paediatric Oncology, Great Ormond Street Hospital, Great Ormond Street, London WC1N 3JH, UK
    Eur J Cancer 41:2280-7. 2005
    ..Influenza vaccine was well tolerated in this patient group and children showed a significant response to immunisation. These findings support the recommendation for annual influenza vaccination in these children...
  4. ncbi request reprint Efficacy of carboplatin given in a phase II window study to children and adolescents with newly diagnosed metastatic soft tissue sarcoma
    J C Chisholm
    Department of Haematology and Oncology, Great Ormond Street Hospital, Great Ormond Street, London WC1N 3JH, UK
    Eur J Cancer 43:2537-44. 2007
    ..The activity of carboplatin was evaluated in a phase II window study in previously untreated children with metastatic soft tissue sarcoma...
  5. ncbi request reprint Toxicity and outcome of children and adolescents participating in phase I/II trials of novel anticancer drugs: the Royal Marsden experience
    Daniel A Morgenstern
    Pediatric Drug Development Unit, Children and Young People s Unit, The Royal Marsden NHS Foundation Trust Pediatric Drug Development Team, Divisions of Cancer Therapeutics and Clinical Studies, The Institute of Cancer Research, Sutton Pediatric Oncology Department, Great Ormond Street Hospital Institute of Child Health, University College London, London, UK
    J Pediatr Hematol Oncol 36:218-23. 2014
    ..Continued expansion of the portfolio is needed ultimately to improve the outcomes for those with resistant disease. ..
  6. pmc Variation in policies for the management of febrile neutropenia in United Kingdom Children's Cancer Study Group centres
    Bob Phillips
    Paediatric Oncology Day Hospital, St James s Hospital, Leeds, UK
    Arch Dis Child 92:495-8. 2007
    ..To assess the variation in the current UK management strategies for the treatment of febrile neutropenia in childhood. Design and..
  7. doi request reprint Vaccinations in children treated with standard-dose cancer therapy or hematopoietic stem cell transplantation
    Soonie R Patel
    Paediatric Department, Mayday University Hospital, Croydon, UK
    Pediatr Clin North Am 55:169-86, xi. 2008
    ..It is important to protect these children against vaccine-preventable diseases by reimmunization...